Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05177653
What this trial is testing

Separate and Combined Extrapancreatic Effects of the Incretin Hormones

Who this might be right for
Pancreatectomy; Hyperglycemia
University Hospital, Gentofte, Copenhagen 13
Early research (Phase 1)Study completedNCT02237053
What this trial is testing

Effects of Glucagon Administration on Energy Expenditure

Who this might be right for
HyperglucagonemiaObesity
AdventHealth Translational Research Institute 6
Testing effectiveness (Phase 2)Study completedNCT03232112
What this trial is testing

Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?

Who this might be right for
Alcohol Dependence, in RemissionAddiction, Alcohol
Anders Fink-Jensen, MD, DMSci 152
Not applicableStudy completedNCT04614168
What this trial is testing

Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes

Who this might be right for
Type 1 DiabetesType 1 Diabetes Mellitus With HypoglycemiaHypoglycemia+3 more
University of Edinburgh 24
Not applicableStudy completedNCT02385617
What this trial is testing

Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer

Who this might be right for
Esophageal NeoplasmsStomach NeoplasmsWeight Loss+1 more
St. James's Hospital, Ireland 20
Not applicableStudy completedNCT00923962
What this trial is testing

Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
University Hospital, Gentofte, Copenhagen 35
Large-scale testing (Phase 3)Looking for participantsNCT07193459
What this trial is testing

Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 360
Not applicableUnknownNCT03543423
What this trial is testing

Studies of the Early Meal Phase in Healthy Individuals - Nutrient Absorption and Gastrointestinal Hormone Secretion

Who this might be right for
Healthy
University of Copenhagen 12
Large-scale testing (Phase 3)Study completedNCT01879917
What this trial is testing

Liraglutide in Newly Onset Type 1 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 1
Hvidovre University Hospital 65
Not applicableStudy completedNCT06017544
What this trial is testing

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 2Myocardial Infarction
University of Campania Luigi Vanvitelli 257
Not applicableNot Yet RecruitingNCT07014709
What this trial is testing

Impact of GLP-1 Receptor Agonists on Patients With IPMN

Who this might be right for
IPMNIPMN, PancreaticGLP-1+2 more
Hôpital Fribourgeois 30
Large-scale testing (Phase 3)Looking for participantsNCT07284901
What this trial is testing

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Who this might be right for
Obesity With DiabetesOverweight With Diabetes
Kailera 1,156
Post-approval studies (Phase 4)Study completedNCT02537834
What this trial is testing

Tofogliflozin GLP-1 Analogue Combination Trial

Who this might be right for
Type 2 Diabetes Mellitus
Kowa Company, Ltd. 65
Testing effectiveness (Phase 2)UnknownNCT06500299
What this trial is testing

Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults

Who this might be right for
Overweight and Obesity
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 180
Large-scale testing (Phase 3)Looking for participantsNCT06825182
What this trial is testing

Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Nanjing First Hospital, Nanjing Medical University 1,000
Post-approval studies (Phase 4)Study completedNCT03533179
What this trial is testing

Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced Cardioinhibition

Who this might be right for
Drug OverdoseOverdose of Beta-adrenergic Blocking Drug
University Hospital Bispebjerg and Frederiksberg 10
Not applicableStudy completedNCT06608433
What this trial is testing

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

Who this might be right for
Healthy Volunteer StudyHPACortisol Deficiency+1 more
University Hospital, Basel, Switzerland 22
Not applicableNot Yet RecruitingNCT06671340
What this trial is testing

Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes

Who this might be right for
Diabetes MellitusPrediabetes / Type 2 Diabetes
Elaine Chow 30
Post-approval studies (Phase 4)Looking for participantsNCT06671587
What this trial is testing

IGlarLixi CGM Study in Chinese T2D Individuals After OADs

Who this might be right for
Type 2 Diabetes (T2D)
Sanofi 678
Not applicableLooking for participantsNCT07207148
What this trial is testing

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Who this might be right for
Multiple Sclerosis
Northwestern University 100
Next Page